Thyroid hormone receptor-β agonist simedeutirom (HSK31679) for Chinese patients with metabolic dysfunction-associated steatohepatitis: a 52-week, multicentre, randomised, double-blind, placebo-controlled, phase 2b trial

The Lancet Gastroenterology & Hepatology · Elsevier

Аннотация

Publication date: Available online 17 October 2026 Source: The Lancet Gastroenterology & Hepatology Author(s): Feng Xue, Jianfeng Liu, Jinjun Chen, Xing Li, Sikui Wang, Yawen Luo, Bangjie Zhang, Jiawei Geng, Weihong Wang, Rui Zhao, Chuanwu Zhu, Junjun Bi, Xiqing Guo, Lungen Lu, Guangming Li, Hong Peng, Li Dong, Weifang Zeng, Tingting Wu, Fangqiong Li

Читать у издателя →

Похожие статьи